CANDY BUSH: Open Payments
NPI 1356013403 · LEBANON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 12 payments from 6 companies in 2025. Trend: 2023 $1,084 · 2024 $717 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| PFIZER INC. | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Novo Nordisk Inc | 2 | $35 |
| ABBVIE INC. | 2 | $31 |
| Lilly USA, LLC | 1 | $24 |
Products named: CAPLYTA, NURTEC ODT, AIRSUPRA, ZEPBOUND, Wegovy, FARXIGA, Ozempic, UBRELVY.
Industry payments across VA — which companies pay providers there.
